
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
26.830
Open
26.750
VWAP
26.73
Vol
638.85K
Mkt Cap
11.74B
Low
26.610
Amount
17.08M
EV/EBITDA(TTM)
9.60
Total Shares
875.93M
EV
14.26B
EV/OCF(TTM)
14.45
P/S(TTM)
1.99
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2029Q2
FY2029Q1
FY2028Q4
1.49B
+5.55%
--
--
1.51B
+4.55%
--
--
1.41B
+1.18%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for Smith & Nephew plc (SNN) for FY2025, with the revenue forecasts being adjusted by 0.3% over the past three months. During the same period, the stock price has changed by 5.89%.
Revenue Estimates for FY2025
Revise Upward

+0.3%
In Past 3 Month
Stock Price
Go Up

+5.89%
In Past 3 Month
3 Analyst Rating

6.23% Upside
Wall Street analysts forecast SNN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNN is 28.47 USD with a low forecast of 27.00 USD and a high forecast of 30.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy

6.23% Upside
Current: 26.800

Low
27.00
Averages
28.47
High
30.70

6.23% Upside
Current: 26.800

Low
27.00
Averages
28.47
High
30.70
Canaccord Genuity
Caitlin Cronin
Hold
Maintains
$27
2025-03-17
Reason
Canaccord Genuity
Caitlin Cronin
Price Target
$27
2025-03-17
Maintains
Hold
Reason
UBS
Graham Doyle
Strong Buy
to
Hold
Downgrades
n/a
2025-03-12
Reason
UBS
Graham Doyle
Price Target
n/a
2025-03-12
Downgrades
Strong Buy
to
Hold
Reason
Canaccord Genuity
Kyle Rose
Hold
Maintains
$27
2025-02-26
Reason
Canaccord Genuity
Kyle Rose
Price Target
$27
2025-02-26
Maintains
Hold
Reason
UBS
Graham Doyle
Hold
to
Strong Buy
Upgrades
n/a
2024-06-05
Reason
UBS
Graham Doyle
Price Target
n/a
2024-06-05
Upgrades
Hold
to
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Smith & Nephew PLC (SNN.N) is 13.70, compared to its 5-year average forward P/E of 18.48. For a more detailed relative valuation and DCF analysis to assess Smith & Nephew PLC 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
18.48
Current PE
13.70
Overvalued PE
22.43
Undervalued PE
14.54
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
11.50
Current EV/EBITDA
9.19
Overvalued EV/EBITDA
13.63
Undervalued EV/EBITDA
9.37
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued
5Y Average PS
2.54
Current PS
1.90
Overvalued PS
3.17
Undervalued PS
1.91
Financials
Annual
Quarterly
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
1.7M
Volume
2
3-6
Months
2.9M
Volume
15
6-9
Months
6.1M
Volume
15
0-12
Months
4.2M
Volume
12
Bought
0-3
1
194.5K
Volume
Months
3-6
8
7.2M
Volume
Months
6-9
7
22.1M
Volume
Months
0-12
13
7.1M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SNN News & Events
Events Timeline
2025-03-04 (ET)
2025-03-04
11:19:18
Smith & Nephew opens door to break-up in response to activist, The Times says


2025-03-04
09:08:11
Smith & Nephew announces its efforts to develop technology in Spatial Surgery

2025-01-14 (ET)
2025-01-14
07:25:18
Smith & Nephew's ALLEVYN dressings, LEAF system receive ECRI ratings

Sign Up For More Events
Sign Up For More Events
News
6.0
03-13Business InsiderSmith & Nephew (SN) Receives a Buy from RBC Capital
4.0
03-12BenzingaThis PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
5.0
03-11NewsfilterSmith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
Sign Up For More News
People Also Watch

ERAS
Erasca Inc
1.400
USD
+0.72%

GOTU
Gaotu Techedu Inc
3.070
USD
+2.68%

GPRK
GeoPark Ltd
7.010
USD
+2.19%

IIIN
Insteel Industries Inc
33.260
USD
+0.79%

SMBK
SmartFinancial Inc
30.120
USD
+0.10%

MXCT
MaxCyte Inc
2.920
USD
+1.39%

MSBI
Midland States Bancorp Inc
16.560
USD
-0.30%

GAMB
Gambling.com Group Ltd
12.790
USD
+0.08%

GEVO
Gevo Inc
1.190
USD
0.00%

GMRE
Global Medical REIT Inc
7.880
USD
+2.47%
FAQ

What is Smith & Nephew PLC (SNN) stock price today?
The current price of SNN is 26.8 USD — it has increased 0.6 % in the last trading day.

What is Smith & Nephew PLC (SNN)'s business?

What is the price predicton of SNN Stock?

What is Smith & Nephew PLC (SNN)'s revenue for the last quarter?

What is Smith & Nephew PLC (SNN)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Smith & Nephew PLC (SNN)'s fundamentals?

How many employees does Smith & Nephew PLC (SNN). have?
